Latest News and Press Releases

NeuroMetrix announced it has entered into a definitive merger agreement whereby electroCore, Inc. will acquire NeuroMetrix.

WOBURN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and nine months ended September 30, 2024. The...

WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today for the purpose of clarity, reiterated that the Company is engaged in a review of strategic alternatives. In...

NeuroMetrix, Inc. today reported financial and business highlights for the quarter and six months ended June 30, 2024.

NeuroMetrix plans to issue its 2024 second quarter business and financial highlights before the opening of the market on August 6, 2024.

NeuroMetrix, Inc. today reported financial and business highlights for the quarter ended March 31, 2024.

NeuroMetrix today announced two steps to enhance shareholder value following feedback and recommendations from one of its largest shareholders.

WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that DPNCheck® combined with standard EKG or DPNCheck...

NeuroMetrix today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in Dec 2022.

NeuroMetrix, Inc. today reported financial and business highlights for the quarter and full year ended December 31, 2023.